More Articles

Hikma makes deal to enhance delivery of generic injectables Generics/News | Posted 06/12/2013

Hikma Pharmaceuticals (Hikma) announced on 20 November 2013 that it had signed a long-term commercial supply contract with Unilife Corporation (Unilife) for the use of Unifill pre-filled syringes w...

Volume components of pharmaceutical expenditure Generics/Research | Posted 29/11/2013

In the third of a series of four articles on pharmaceutical expenditure, Vogler and co-authors explain the different methodological approaches to measuring pharmaceutical utilization and outline so...

Non-clinical study shows similarity of biosimilar etanercept Biosimilars/Research | Posted 29/11/2013

The results of a non-clinical study of a candidate biosimilar etanercept (GP2015) has shown the similarity, with respect to in vitro and in vivo characteristics, of the biosimilar (GP2015) and its...

Indian regulator approves first trastuzumab ‘similar biologic’ Biosimilars/News | Posted 29/11/2013

India’s drug regulator, the Drugs Controller General of India (DCGI), has granted marketing approval for the world first trastuzumab ‘similar biologic’.

Pennsylvania moves closer to adopting biosimilars legislation Policies & Legislation | Posted 29/11/2013

Pennsylvania has taken a step closer to adopting legislation which would authorize pharmacists to be able to substitute FDA-approved biosimilars for their reference biologicals, but with certain re...

Survey highlights the importance of unique names for biosimilars Biosimilars/General | Posted 29/11/2013

A report released by the Alliance for Safe Biologic Medicines (ASBM) on 22 November 2013 highlights the importance of using unique names for identifying biosimilars.

Health Canada approves generic oxycodone despite fears of abuse Pharma News | Posted 29/11/2013

Canada’s drug regulator Health Canada has approved a generic non-crush resistant form of oxycodone, despite the fact that US officials have been urging their Canadian counterpart to ban such formul...

Merck Serono to transfer technology for six similar biotherapeutic products to Brazil Biosimilars/News | Posted 29/11/2013

The Brazilian Ministry of Health (Ministério da Saúde) announced on 7 November 2013 a partnership between Brazil’s Bionovis, Fiocruz and Instituto Vital Brazil (IVB) with Germany’s Merck Serono for...